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Highlights 
 Available evidence suggests incomplete effectiveness of protective barriers of the brain
against nanoparticles translocation to the brain 
 Nanoparticles from continuously growing industrial production and the use of
nanoparticles may impact human brain health 
 There is a need to specifically evaluate the interactions between nanomaterials and the
nervous system: with original dedicated experimental models and tools for 
neurotoxicological research, with epidemiological studies of neurodegenerative diseases 
in manufactured nanoparticle-exposed populations 
 This review warrants recognition of an emerging need to combine nanotoxicology and
neurology and calls for novel specific tools and investigation methods for this discipline 
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Abstract 
The present critical review analyzes the question of how nanoparticles from continuously 
growing industrial production and use of nanomaterials may impact human brain health. 
Available evidence suggests incomplete effectiveness of protective barriers of the brain 
against nanoparticles translocation to the brain. This raises concerns of potential effects of 
manufactured nanoparticles on brain functions, given that nanoparticle’s potential to induce 
oxidative stress, inflammation, death by apoptosis, or changes in the level of expression of 
certain neurotransmitters. Most concerns have not been studied sufficiently and many 
questions are still open: Are the findings in animals transposable to humans? What happens 
when exposure is chronic or protracted? What happens to the developing brain when 
exposure occurs in utero? Are some nanoparticles more deleterious, given their ability to 
alter protein conformations and aggregation? Aside from developments in nanomedicine, 
the evidence already available fully justifies the need to specifically evaluate the interactions 
between nanoparticles and the nervous system. The available data clearly indicates the need 
for original dedicated experimental models and tools for neurotoxicological research on the 
one hand, and the need for epidemiological studies of neurodegenerative diseases in 
manufactured nanoparticle-exposed populations, on the other. A combination of 
nanotoxicology with neurology in a novel discipline, with its specific tools and methods of 
investigation, should enable answering still unresolved questions. 
Abbreviation list 
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α, alpha; β, beta; δ, delta; ε, epsilon; APOE, apolipoprotein E ; Aβ, amyloid beta; BBB, blood–
brain barrier; CERAD, The Consortium to Establish a Registry for Alzheimer's Disease; CNS, 
central nervous system; CRP, C reactive protein; CSF, cerebrospinal fluid; DRG, dorsal root 
ganglia; EBC, exhaled breath condensate; H2O2, hydrogen peroxide; HCECs, human cerebral 
endothelial cells; HR, hazard ratios ; IL, Interleukin; MDA, malondialdehyde; MIG, metal inert 
gas; MMSE, Mini-Mental State Examination; NPs, nanoparticles ; PEG, polyethylene glycol ; PM 
particulate matter; PNC, particle number concentration; PNS, peripheral nervous system; 
QD, quantum dots ; ROS, reactive oxygen species; SiO2, silica dioxide;  TIG, Tungsten Inert 
Gas; TiO2, titanium dioxide ; TNF-α, tumor necrosis factor- alpha; UFPs, ultrafine particles ; 
ZnO, zinc oxide;  
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1. Introduction
It is advisable today to distinguish between ultrafine particles characterized by various sizes, 
shapes and compositions, either of natural origin (erosion, volcanic eruptions) or anthropic 
activities (traffic, combustion and some industrial activities), and manufactured 
nanoparticles. The latter are produced intentionally in the framework of the flourishing 
nanotechnologies. Unlike ultrafine particles (UFPs), manufactured nanoparticles are 
produced for their particular properties shown only at the nanoscale, and have more 
controlled physicochemical characteristics. The properties exhibited at this scale (between 1 
and 100 nm) can be of diverse type, i.e. electric, catalytic, mechanical, optical, or biological, 
enabling use of nanotechnology products in almost all the major sectors in today’s world, 
including health, energy, electronics, the environment, and transport and information 
technology and telecommunications. This explains the enthusiasm of industry and the public 
authorities for these products. The use of manufactured nanoparticles in medical 
applications is particularly remarkable, including for diagnostic purposes, treatment of 
cancers, molecular imagery, surgery, and medical devices or tissue engineering (Bechet et 
al., 2008; Benachour et al., 2012; Chouikrat et al., 2012; Koffie et al., 2011; Wadghiri et al., 
2013; Zhang et al., 2013). The development of optimized tools to diagnose, study, and treat 
central nervous system (CNS) diseases, including tumors or neurodegenerative diseases 
reputed incurable, is one of the expected applications in nanomedicine. Carbon-based 
(Riviere, 2009) and metallic nanoparticles (Yokel et al., 2013) are already widely used, 
especially for imaging. Nanoparticles may resolve key problems such as penetration and 
targeting of specific brain areas, difficulties resulting from the high level of protection of this 
particular organ. This is why some studies dealing with nanomedicine (in vitro, in vivo and 
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more rarely human studies) have focused mainly on the interactions between  nanoparticles 
and the nervous system, and on drug delivery systems (like polymer-based, dendrimers, 
nanoliposomes ...) that target the CNS. Despite the different strategies that are currently 
used to overcome the remaining hurdles for nanoparticle transfer to the brain (increasing 
nanoparticle dose, use of polyethylene glycol (PEG) or other surface modifications), there is 
still little evidence that  nanoparticles reach the brain in vivo, and there is a lack of studies 
about possible deleterious effects of these  nanoparticles. Indeed, precautions must be 
taken in the use of these nano-designed treatments, as nanoparticles may also induce 
neurotoxic effects or accelerate existing brain damage (Figure 1). 
Moreover, in addition to nanomedicine products that concern vulnerable populations, the 
rapid spread of nanotechnology raises serious questions about its impact on the general 
population’s health and on the environment. Thousands of nanoproducts are already 
available on the market (JRC, 2014) (Tulve et al., 2015; Vance et al., 2015), raising concerns 
of massive consumer exposure by inhalation, ingestion, dermal contact, or a combination of 
these routes. While several studies have already pointed to possible respiratory and 
cardiovascular system damage following nanoparticle exposure (Cassee et al., 2011; Dockery 
et al., 1993; Ghio et al., 2012; Liao et al., 2014; McCreanor et al., 2007; Miller et al., 2013; 
Patel et al., 2013; Pieters et al., 2012; Pope et al., 2008; Pope et al., 2006; Robertson et al., 
2012; Robertson et al., 2014; Seaton et al., 1995; Thurston et al., 2016; Xu et al., 2013b; 
Yamamoto et al., 2013), only few studies have looked at their impact on the highly 
vulnerable nervous system as underlined in several reviews (Cupaioli et al., 2014; Lung et al., 
2014; Suh et al., 2009; van Berlo et al., 2014; Yokel, 2016a; Yokel and Macphail, 2011). 
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This review aims to 1) describe possible exposure routes and consequences of manufactured 
nanoparticles on the function and integrity of the nervous system in light of their specific 
structural and physiological properties, 2) assess the evidence in humans, with particular 
focus on neurodegenerative and neurodevelopmental outcomes, and 3) identify 
methodological and research gaps and possible solutions for a better understanding of how 
manufactured  nanoparticles may affect the human nervous system.  
2. The brain: a particularly vulnerable and highly protected organ
Compared to the other organs, the brain is unique in several ways (Figure 2): 1) high 
metabolic needs, for a cerebral mass accounting for approximately 2% of the whole body, 
the brain consumes nearly 20% of the total oxygen inhaled, making it one of the most active 
organs at the metabolic level; 2) complex organization with hundreds of neuroanatomic 
regions namely the “nuclei” having different sensitivities to physical or chemical insults; 3) 
specific cells with unique properties, the neurons, highly specialized to allow electric and 
chemical conduction; the glial cells (80% of CNS cells) responsible for myelination of the 
neuronal processes, metabolic support and regulation of neuronal synaptogenesis or 
chemical transmission within a synapse, as well as responses to brain damage; and 4) several 
levels of protection including the ventricular spaces filled with cerebrospinal fluid (CSF) that 
have a crucial function in preserving brain homeostasis by regulating the maintenance of the 
integrity of the CSF–brain barrier, but also the blood–brain barrier (BBB), a regulator of the 
flow of molecules between the blood circulation and cerebral parenchyma, also involved in 
the elimination of toxic metabolites and protection of the brain against xenobiotic agents 
(Abbott et al., 2006). Finally, the brain is highly vulnerable by nature, as it is extremely 
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sensitive to hypoxia, inflammation, and oxidative stress, and has very limited regenerative 
capacity of the neurons. 
3. Routes for nanoparticles to reach the brain
The main paths of exposure to nanoparticles in humans are the respiratory route, which 
includes the nasal cavity, but also the digestive tract and potentially the cutaneous route 
(Buzea et al., 2007) (Figure 3). Once  nanoparticles successfully cross these first barriers, the 
lungs, the gastrointestinal tract, or the skin, they may attain the blood stream, and next the 
brain, especially if they can cross the BBB. The possibility of  nanoparticles reaching the brain 
via these various routes of exposure is supported by experimental evidence accumulated 
over the last fifteen years and Figure 3 provides a sum up of possible routes transposed to 
humans. 
3.1. Neuronal uptake and transportation of nanoparticles 
3.1.1. From nose to brain 
A first and direct possibility of neuronal translocation is after inhalation, from the nasal 
cavity to the brain through the olfactory bulbs directly accessible from the nasal fossae. The 
demonstration of nanoparticle uptake from the nasal cavity to the brain can be found in a 
study using squirrel monkeys exposed intranasally to 50 nm colloidal gold (De Lorenzo, 
1970). The gold nanoparticles detected by electron microscopy, were seen in the olfactory 
nerve within 30 min after exposure and in mitral cells of the olfactory bulb 1 hour after 
exposure (De Lorenzo, 1970). In 2004 Oberdörster’s team showed that nanoparticles of 13C 
of approximately 36 nm could be transferred straightaway from the olfactory epithelium to 
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the olfactory bulbs via olfactory nerve neural processes (Oberdorster et al., 2004). Since 
these studies, the observation has been repeated for other types of nanoparticles, such as 
those of manganese or iron oxide (Elder et al., 2006; Wang et al., 2007a). Thus a direct 
neuronal uptake of nanoparticles is possible and it is reasonable to assume that 
nanoparticles could be then transported to more distant brain areas, using the neuronal 
retrograde transport. Indeed the uptake of particulate matter, such as pigment particles or 
viruses (such as 30 nm poliovirus, 80 to 100 nm herpes virus …), followed by their neuronal 
retrograde transport along the olfactory tract is reported and admitted since a long time ago 
(Howe and Bodian, 1941; Rake, 1937). But even today, the exact mechanism of 
Nanoparticles uptake by sensory endings and their translocation to the brain are not 
understood. 
Neuronal transport 
It is well-known that neurons are able to internalize not only pathogens, toxins but other 
types of molecules such as trophic factors. Once inside the neurons, these molecules can be 
transported using either anterograde or retrograde axonal transport machinery (Gibbs et al., 
2016; von Bartheld, 2004). The retrograde transport is mostly driven by cytoplasmic dynein, 
a protein that sustains the transport of various organelles such as vesicles, mitochondria, 
endosomes, lysosomes etc.…from the axon terminals to the neuronal cell bodies. It is usually 
accepted that axonal transport can be ‘fast’ (200–400 mm/day or 2 to 5 μm/s) or ‘slow’ (1–5 
mm/day) (Shepherd, 1994). The fast transport with an average speed of 1 to 2 μm/s (Cui et 
al., 2007; Ori-McKenney et al., 2010), can be however less (0.4 μm/s) or more rapid (up to 5 
μm/s) (Hill et al., 2004; Kural et al., 2005; Parton et al., 1992) depending on the model 
studied (Cui et al., 2007; Ori-McKenney et al., 2010) More recently, some studies have 
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brought evidence supporting the attractive speculation that Nanoparticles could be 
internalized by endocytosis and then transported using this retrograde machinery. For 
example, using a zinc binding dye, airborn ZnO particles (12-14 nm) were detected in the 
olfactory bulbs and brains of rats exposed 4h on 3 consecutive days using transmission 
electron microscopy (Kao et al., 2012). To test the olfactory uptake and axonal transport, 
quantum dots (QD) made of CdSe/ZnS nanocrystals were used in inhalation studies in mice 
(droplets size 84 nm at an average concentration of 250 μg/m3 for 1 hour) (Hopkins et al., 
2014). In this study, several techniques, including fluorescent and transmission electron 
microscopy on tissue samples that were previously washed and exsanguinated, allowed 
demonstrating that QDs were quickly transported from the nose to the brain mainly by 
olfactory uptake and via fast axonal transport. Axonal translocation was also reported for 
CeO2 and SiO2 Nanoparticles in frog sciatic nerve (ex vivo preparation) and the measured 
speed of translocation was compatible with the slow axonal transport (Kastrinaki et al., 
2015). Computational studies may further clarify our understanding of the axonal transport 
of nanoparticle. Notably, Kuznetsov (Kuznetsov, 2012) provided a model of nanoparticle 
transport in neurons and described two modes of neuronal transport, depending on the 
intracellular location of Nanoparticles, inside or outside of endocytic vesicles. Assuming that 
in axons, Nanoparticles would be internalized only at axon terminals, and in dendrites, in 
which Nanoparticles could enter anywhere through the entire plasma membrane, this 
mathematical model integrated the differences between axons and dendrites 
compartments, resulting from these different uptake possibilities. The development of 
nanoparticle based tools for studying the function of dyneins on retrograde transport of 
endosomes in neurons (Chaudhry et al., 2008) also confirms the relevance of the 
nanoparticle translocation using the retrograde axonal machinery. Functionalization of 
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Nanoparticles enables them to be endocytosed and transported. It was shown by a study 
using nerve growth factor conjugated quantum dots that enter DRG neurons and are then 
transported axonally in a retrograde manner (Cui et al., 2007). 
An additional main pathway to reach the CNS implicates the trigeminal nerve (Dhuria et al., 
2010), a small portion of which terminates in the olfactory bulbs (Schaefer et al., 2002). The 
trigeminal and olfactory pathways of nanoparticles allow direct translocation to the brain 
(Elder et al., 2006; Lewis et al., 2005). These data suggest an innovative gateway of entrance 
into the CNS for Nanoparticles, avoiding the blood–brain barrier (Johnson et al., 2010). 
Trans-synaptic transportation 
The observation that several levels of brains areas connected to the nasal fossae through 
olfactory and trigeminal nerves were shown to contain inhaled Nanoparticles, suggests by 
itself that Nanoparticles could pass from a neuron to another through the synapses. 
Olfactory sensory neurons synapse on mitral cells, are themselves connected with tufted 
cells. From the olfactory bulbs, these neurons pass through to the olfactory tubercle and 
then a third-order neuronal projections (third synaptic contact) result in connections with 
several brain areas such as the anterior olfactory nucleus, prepyriform and the entorhinal 
cortex, the amygdala, as well as the hippocampus, hypothalamus and thalamus (Lledo et al., 
2005). Most of the inhalation studies reported clearly nanoparticle deposition within the 
olfactory bulb (first order synapse) (De Lorenzo, 1970; Elder et al., 2006; Hopkins et al., 2014; 
Oberdorster et al., 2004; Wu et al., 2013). From there, Nanoparticles might travel to other 
areas of the brain (e.g., hippocampus, hypothalamus, etc.), following the olfactory and 
trigeminal pathways (Lledo et al., 2005). This property should be particularly taken into 
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account in the drug delivery strategies based on nasal instillation (Illum, 2000) (Mistry et al., 
2009). The ability of Nanoparticles to pass the synapses between olfactory neurons in the 
olfactory bulb to the telencephalon and diencephalon structures or from trigeminal nerves 
to the projections from the spinal trigeminal nucleus are difficult to apprehend and might 
appear as less efficient (Oberdorster et al., 2004; Tjalve et al., 1996). Several parameters 
could explain this difficulty, first a question of time: nanoparticle axonal and trans-synaptic 
transport needed to reach other areas of the brain supposes more time. Secondly, a dilution 
effect during trans-neuronal dissemination and thirdly a potential clearance of some of the 
Nanoparticles during the journey. 
Extracellular pathways excluding blood 
In addition to the neuronal pathway, nanoparticles could gain access to the CNS through the 
extracellular pathways (perineuronal, perivascular and cerebrospinal fluid pathways). As an 
example, to comfort initial inhalation studies using uranium aerosol (Tournier et al., 2009) in 
rats, that suggested the existence of an olfactory transport, a second wave of experiments 
using instillation of soluble uranium in the nasal cavity was performed (Ibanez et al., 2014). 
Using SIMS microscopy, the analysis revealed that the uranium has been brought directly 
along the olfactory nerve to the brain through perineural and cerebrospinal fluid pathways. 
3.1.2. From lungs to the brain 
Translocation to the CNS after inhalation has been reported for Nanoparticles of very 
different chemical types and sizes: ferric oxide (Wang et al., 2016) silver (Patchin et al., 
2016), gold (Yu et al., 2007; Zhang et al., 2012), copper (Zhang et al., 2012), titanium dioxide 
(TiO2) (Wang et al., 2008a; Wang et al., 2008b), manganese dioxide (Elder et al., 2006), 
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iridium (Kreyling et al., 2009), and carbon (Kreyling et al., 2009), with dimensions reaching 
from 2 to 200 nm. It was also reported in the context of anthropic nanoparticles (Shimada et 
al., 2006). During inhalation, passage of nanoparticles from the lungs to the brain has also 
been suggested (Oberdorster et al., 2005; Oberdorster et al., 2004). In this case, it would 
appear that translocation to the brain results predominantly from secondary translocation, 
following preliminary nanoparticle crossing of the lung–blood barrier. It has been shown that 
metal nanoparticles, for instance uranium (38 nm) (Petitot et al., 2013), are translocated 
from the respiratory tract to extra-pulmonary organs, particularly the CNS, via blood 
capillary vessels (Simko and Mattsson, 2010). The presence of sensory nerve endings at the 
bronchiolar and alveolar level could also support the neuronal translocation of 
nanoparticles. As an example, C-nerve fibers present within the airways ending in the 
solitary nucleus and para-trigeminal nucleus within the medulla oblongata (McGovern et al., 
2015) might contribute to the uptake and translocation to the brain. A review by Stapleton 
et al. points out several neurological links that may sustain the observed cardiovascular 
responses to xenobiotic pulmonary exposure (Stapleton et al., 2015). However there is a lack 
of data reporting nanoparticle neuronal uptake and retrograde transportation by this way. 
3.1.3. From gut to the brain 
The digestive tract appears to be another route of translocation after inhalation of 
nanoparticles; this well-known pathway can be studied specifically by intra-esophageal 
instillation. A very recent study by Kreyling et al. (Kreyling et al., 2017) investigated with a 
remarkable precision the quantitative biodistribution of TiO2 NPs in rats after a single dose 
delivered by intra-esophageal instillation. They showed that despite very low absorption of 
TiO2 nanoparticles across the gut (less than 0.6% of the dose applied), and despite the 
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physiological barriers of the CNS, TiO2 nanoparticles were detectable weakly but clearly in 
the brain. This study does not allow determining precisely the cellular location of these 
nanoparticles (nervous cells, endothelial cells) neither the precise pathways (blood, 
neuronal) that contribute to this translocation in the brain. But, compared to other organs, 
these nanoparticles still detectable in the brain seven days after oral delivery suggest 
importantly retention of nanoparticles in this organ (Kreyling et al., 2017). Similar 
observation was reported for 80nm gold nanoparticle but with lower retention (Schleh et al., 
2012). Furthermore, the possibility of nanoparticle passage from the gastrointestinal tract to 
the brain has been studied by direct exposure via drinking water or by gavage. The study of 
Hillyer and Albrecht investigated gold nanoparticle content in gastrointestinal tract and brain 
after 4, 10, 28 and 58 nm diameter colloidal gold nanoparticle oral delivery (Hillyer and 
Albrecht, 2001). The authors report nanoparticle accumulation in brain with the highest 
concentration recorded for 4nm nanoparticles and less strong but similar concentration for 
10 and 58 nm. Other studies (Hu et al., 2010; Wang et al., 2007b; Wang et al., 2013) suggest 
nanoparticle accumulation in the brain after oral exposure, combined to dose-dependent 
brain damage, based on prior passage of the nanoparticles in the systemic circulation. 
However for all these studies it is not possible to distinguish the parenchymal from the blood 
nanoparticle content. A study on female rats exposed to a unique oral dose of iron oxide 
(Fe2O3 (30nm)) at different concentrations, has also showed, although with slight levels, a 
dose dependent content in Fe2O3 in the brain that was more effective for the nanoforms 
compared to the control bulk material (Singh et al., 2013). It is plausible that before being 
transported in a retrograde manner to the brain, nanoparticle could be captured by the 
numerous nerve endings along the digestive tract (Furness et al., 2013) Yet, this pathway has 
not been addressed in the nanotoxicology literature. It requires a thorough evaluation, 
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notably in a context of growing exposure by this route, to relatively high levels of engineered 
nanoparticles (Weir et al., 2012) and given the recent hypothesis in Parkinson disease (PD) 
etiology (Hawkes et al., 2007). According to Braak’s theory, PD could be initiated outside the 
central nervous system, in peripheral areas, such as olfactory bulbs and enteric nervous 
system present in the gut, possibly triggered by xenobiotic agents that would be taken up 
locally and initiate neurotoxicity (Braak et al., 2006). This hypothesis was experimentally 
studied and sustained only recently (Pan-Montojo et al., 2012). 
Concerning oral exposure during critical periods of life like in newborns, a very recent study 
suggests that infants can be exposed to silver and gold nanoparticles via breastmilk 
(Morishita et al., 2016). Silver nanoparticles administered intravenously or orally to lactating 
mice resulted in silver nanoparticle detection in breastmilk, and subsequently silver 
nanoparticles were found to accumulate in the brains of offspring. During the earliest 
months of life, the young mice did not show any neurologic abnormalities. However, the 
consequences of nanoparticle exposure on brain function may appear on a longer time scale 
and thus this should be evaluated. 
3.2. Neuronal translocation of nanoparticles through the blood brain barrier 
Regardless of the route of exposure, it would seem that nanoparticles could quickly reach 
the blood vessels, (Ragnaill et al., 2011; Sharma and Sharma, 2007; Zensi et al., 2009) via 
transcytosis through endothelial cells rather than between endothelial cells. Translocation 
from blood compartment through endothelial cells to reach the brain has been 
demonstrated in vivo in the mouse after intravenous injection of nanoparticles 
functionalized with Apo-E molecules (Kreuter et al., 2002; Zensi et al., 2009). These 
nanoparticles were identified in endothelial cells of the BBB 15 min after administration, and 
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in neurons 30 min after administration (Zensi et al., 2009). This was also shown in vitro for 
TiO2 nanoparticles, which were detected within the endothelial compartment, then in 
astrocytes (Brun et al., 2012). The distribution of nanoparticles in the bloodstream raises a 
particular concern of placental nanoparticle transfer to the fetal CNS (Figure 3). Because the 
BBB develops gradually in the fetal brain (Ballabh et al., 2004), this type of direct exposure to 
nanoparticles in utero may have the most damaging consequences. Best studied in rodents, 
in which the BBB develops anatomically between embryonic day 11 and 17, the temporal 
development of an operational BBB has been found to vary with species (Ballabh et al., 
2004). In addition, complete BBB functionality may need additional time, as shown in the rat 
brain by the increase of the expression of occludin, a tight junction protein expressed by BBB 
endothelial cells, between postnatal day 8 and 70 (Hirase et al., 1997). 
3.3. The case of the peripheral nervous system 
In case of dermal contact with nanoparticles, the peripheral nervous system (PNS) may be 
the first nervous compartment to be concerned by possible nanoparticle uptake and 
consecutive harmful effects. As an example, the presence in the superficial layers of the 
epidermis of free sensory nerve endings of C- and Aδ-fibers that innervate the skin 
represents a possible gateway of entrance of nanoparticles into the brain. In the event of 
nanoparticle uptake by these afferent sensory nerve endings, the substances may be 
transported through neuronal processes to their neuronal cell bodies grouped in the dorsal 
root ganglia (DRG), as discussed in the previous subsection. Secondarily from DRG, 
nanoparticles may pass through synapses in the spinal cord to reach neurons in the CNS. This 
pathway of nanoparticles in the PNS has been poorly investigated despite its importance, 
particularly considering that hundreds of consumer products containing nanoparticles are 
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designed for dermal application. Constitutively, neurons of the PNS are secured by a blood–
neuron barrier thanks to the existence of tight junctions in the endothelial cells surrounded 
by pericytes. However, a noticeable difference with the CNS lies in the absence of foot 
processes from astrocytes at this barrier, and in the presence of Schwann cells instead of 
oligodendrocytes. These features may sustain PNS susceptibility to nanoparticle exposure 
that requires particular attention. 
4. Cellular and subcellular locations of manufactured nanoparticles
Once in the brain, where can we find these nanoparticles? In vitro studies have helped to 
highlight the existence of nanoparticles in neurons, astrocytes and microglial cells, but 
potentially all cell types in the brain could be involved. Once in neurons or glial cells, the 
nanoparticles may be directed to the lysosomes or persist in the cytoplasm, offering the 
opportunity to interact with other organelles. Electron microscopy studies have shown the 
presence of nanoparticles within the glial and neuronal cells for instance silver nanoparticles 
of 20 nm were found mostly in the lysosomes of astrocytes (Haase et al., 2012; Locht et al., 
2011), silica based nanoparticle engineered for nanomedicine tools, was detected in the 
endoplasmic reticulum (ER) and in the cytoplasm of microglial cells (Ducray et al., 2017), as 
wells TiO2 nanoparticles were detected in the cytoplasm and in vacuoles of microglia (Long 
et al., 2006). This indicates that certain nanoparticles may be subject to classic cell 
degradation processes. More rarely, nanoparticles (like silver nanoparticles of 6-20 nm and 
cationic quantum dots (QD) of 2.2 nm) have been found in the nucleus (Asharani et al., 2009; 
Lovric et al., 2005), suggesting that the subcellular location can be highly reliant on the 
dimension of the nanoparticles. Surprisingly, the mitochondrial compartment of nerve cells 
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has not been identified as hosting nanoparticles, except in the study of De Lorenzo in which 
spherical 50nm gold nanoparticles were reported within the mitochondria of the mitral cells 
of the olfactory bulb (De Lorenzo, 1970). The lack of other evidence of mitochondrial 
implication results probably and predominantly from many research gaps in this area. Given 
that oxidative stress is regularly reported in association with exposure to nanoparticles, it is 
very likely that mitochondria host nanoparticles more frequently, as demonstrated for other 
cell types such as macrophages (Eidi et al., 2012). 
5. Possible effects on the nervous system
Given the proven possibility of nanoparticles to reach the nervous system, together with the 
subcellular detection of these nanoparticles within nervous cells, several factors are to be 
taken into attention for the study and understanding of the possible effects on peripheral 
and central nervous system. In the case peripheral nervous system, according to Jaiswal et 
al., SiO2-nanoparticles exert differential cytotoxic effects on PNS neural cells and Schwann 
cells are more susceptible than DRG cells (Jaiswal et al., 2011). In more recent times, it has 
been proved that TiO2-nanoparticles are taken on in DRG cells and generate apoptosis, 
produce reactive oxygen species (ROS) and changes in expression of pro-inflammatory 
cytokines (Erriquez et al., 2015). Further implication of the PNS has also been shown in rats 
exposed repeatedly to lead nanoparticles (20 nm) by intratracheal instillation (Oszlanczi et 
al., 2011). The action potential as well as conduction velocity of the tail nerve were altered in 
the exposed animals. 
In the case of the CNS, it is important to consider the regional dimension of the brain 
affected by the presence of nanoparticles. In brain areas ensuring specific roles, a variety of 
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impacts are likely to be possible. It may be noted, for example, that the presence of 
nanoparticles in the BBB can induce changes in barrier properties. Similarly, interactions of 
nanoparticles with the hippocampus could be linked to memory impairment (Liu et al., 
2012a). The nature of the possible consequences is also reliant on the cell type targeted. 
Schematically, the presence of nanoparticles in astrocytes may participate in the induction of 
reactive gliosis, while in the case of nanoparticle accumulation in neurons, there may be 
changes in neuronal metabolism, functions, or even viability. Finally, the sub-cellular scale 
also has its own importance, as suggested by a study reporting the loss of β-tubulin and actin 
filamentin cultured neurons exposed to 20 nm silver nanoparticles (Xu et al., 2013a); this 
observation was reproduced at sublethal concentrations of silver nanoparticles which 
disrupt also actin dynamics in SVZ-NSCs (Cooper and Spitzer, 2015). Among the possible 
expected effects, impacts on cell morphology, function, and viability are critical for the 
highly vulnerable nerve cells, when compared to other cell types. 
Since neurons ensure the transfer of information, it is key to note that variations in electrical 
activities have been documented, including studies on neurons isolated from the 
hippocampus (Liu et al., 2012b; Xu et al., 2009; Zhao et al., 2009), or studies of primary 
murine cortical networks (Gramowski et al., 2010). These studies indicate that silver 
nanoparticles (50-100 nm, 10 μg/mL) inhibited postsynaptic currents in neurons from the 
CA1 region of the hippocampus, and that ZnO nanoparticles (20-80 nm, 10-4 g/mL) are able 
to increase the entry of sodium ions and the output of potassium ions from the neurons of 
the CA3 region, enhancing their excitability while CuO nanoparticles had small effects on 
transient outward potassium current. In primary cell cultures from the mouse frontal cortex, 
TiO2 nanoparticles at 10 μg/mL induced severe inhibition of the electrical activity of the 
neural network. 
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The review by Simko and Mattsson (Simko and Mattsson, 2010) provides a summary of 
possible neurotoxic outcomes associated with exposure to nanoparticles; other reviews 
(Heusinkveld et al., 2016; Win-Shwe and Fujimaki, 2011; Yokel, 2016b) support the idea of a 
wide range of possible effects. Morphological changes such as number and length of 
neurites or astrocytes branches were reported for example in vitro, in neurons (rat DRG 
primary cells) exposed to Cu nanoparticles (40, 60 and 80 nm) (Prabhu et al., 2010), as well 
as in astrocytes exposed to ZnO nanoparticles (rod shaped 45 nm)(Wang et al., 2014). In 
vivo, morphological changes can also be seen, like in the hippocampus of mice repeatedly (3 
times/week for 4 weeks) exposed to ZnO nanoparticles (20-80nm) by intraperitoneal (i.p.) 
injection at 5.6 mg/kg body weight (Tian et al., 2015). Observed in two vulnerable parts of 
the hippocampus, the CA1 and dentate gyrus (DG) regions, the morphological changes 
affecting pyramidal neurons consisted in a sparse arrangement, cellular distortions, 
dissolved and less numerous Nissl bodies. Neurotoxicity induced by nanoparticles exposure 
can be mediated by oxidative stress, characterized by overproduction of various reactive 
oxygen species (ROS). It is ascertained by the evaluation of the ROS production levels 
combined to the presence of antioxidant defenses (Hellack et al., 2017). This has been 
extensively studied in vitro and in vivo notably for metallic nanoparticles such as ZnO (Guo et 
al., 2013; Tian et al., 2015; Wang et al., 2014), iron oxides (Wu et al., 2013), TiO2 (Huerta-
Garcia et al., 2014; Long et al., 2006; Ma et al., 2010), silver (Haase et al., 2012) but also 
shown for non-metallic nanoparticles such as for fullerenes (C60) (Oberdorster, 2004). 
Neurotoxicity induced by nanoparticles can also be mediated by induction of an 
inflammatory state that can be assessed by different approaches like detection of an up-
regulation of the transcription of various pro-inflammatory genes, of cytokines production, 
and in the brain an activation of microglial cells. As an example, in vivo, it has been shown 
22 
that TiO2 nanoparticles induce cerebral inflammation (Elder et al., 2006) via activation of 
microglial cells in the brain (Balvay et al., 2013). These aspects are very important given the 
high sensitivity of the CNS to oxidative stress and inflammation (Appel et al., 2010; Brochard 
et al., 2009; Glass et al., 2010; Perry et al., 2007; Pott Godoy et al., 2008; Tansey and 
Goldberg, 2010; Wu et al., 2002). More radically, the possibility of neuronal cell death by 
apoptosis has been described in vitro and in vivo, specifically in the context of exposure 
during development (Shimizu et al., 2009). This possibility is particularly worrying for the 
brain, which has very limited regenerative capacity. Importantly for brain function, changes 
in neurotransmitter expression have been identified in vitro and in vivo (Hu et al., 2010; 
Hussain et al., 2006; Wang et al., 2009). As an example, TiO2 nanoparticles administered by 
ingestion are able to deregulate the monoaminergic and serotonergic systems in mice (Hu et 
al., 2010). These changes can further result in behavioral abnormalities, and altered spatial 
memory or motricity, as shown by a significant decrease in locomotor performance (Balvay 
et al., 2013). In a very significant manner, it has been shown that some nanoparticles have 
the ability to accelerate aggregation of certain proteins such as β-amyloid protein, and α-
synuclein protein, demonstrated more recently (Alvarez et al., 2013; Linse et al., 2007). Of 
note, accumulation of these aggregated fibrillar proteins is typical of human 
neurodegenerative diseases such as Alzheimer's disease or Parkinson's disease. In this 
context, a plausible impact of nanoparticles on brain function could be an induction or 
acceleration of these human proteinopathies. The effect induced could be reliant on the 
dimension and concentration of the nanoparticles, as indicated by Alvarez et al. (Alvarez et 
al., 2013). They showed that 10 nm gold nanoparticles can lead to a 3-fold increased speed 
of α-synuclein aggregation at concentrations as low as 20 nM (Alvarez et al., 2013). 
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The list of possible nanoparticle effects is still lacunar, since there are very few relevant 
studies on the subject. The list should clearly be completed with the indirect effects, 
unrelated to nanoparticle accumulation in the brain. When exposure to nanoparticles is not 
sufficient to induce severe changes in the affected target organs or systems (liver, lungs, 
cardiovascular system, and circulating monocytes), it may however induce peripheral 
changes and result in indirect neurotoxicity, mediated by circulating cytokines synthesized 
by the affected organs. Cytokines are known to be able to promote the onset or the 
acceleration of brain disorders (Perry et al., 2007; Pott Godoy et al., 2008), whether they 
alter the integrity of the BBB or not (Murta et al., 2015). 
6. Evidence from epidemiological and human exposure studies
Although no epidemiological data have specifically investigated the neurotoxic effects of 
manufactured nanoparticles, studies of populations exposed to anthropic nanoparticles 
provide an interesting perspective on the concerns related to the possible effects of 
nanoparticles described above in humans. Studies of workers exposed to occupational 
pollutants released at the nanoscale (welding fumes and other non-intentional combustion-
related, mineral or metallic nanoparticles) present the greatest interest for assessing this 
evidence. 
6.1. Studies of nanoparticulate components of welding fumes and their effects on human 
central nervous system 
Exposure characterization studies have shown that welding entails release of metal, but 
their elemental composition and size vary depending on the welding process, the electrode, 
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the material being welded, and many other parameters (Buonanno et al., 2011). For 
example, fumes from metal inert gas (MIG) soldering consisted of 60% zinc, 17% copper, 1% 
iron, and 0.3% manganese, whereas MIG welding of aluminum generated fumes with 51% 
aluminum, 5% magnesium, and 0.1 manganese (Hartmann et al., 2014). In 2014, Andujar et 
al. found predominantly iron of around 20-25 nm, but also chromium and/or manganese, 
titanium, aluminum, silica and nickel in the lung tissue sections of welders (Andujar et al., 
2014). Regarding tungsten inert gas welding, Graczyk et al. (2016a) (Graczyk et al., 2016a) 
reported that iron was a minority among elements measured at the welders’ breathing zone, 
mostly composed of aluminum and tungsten nanoparticles of 45 nm in average. However, 
Miettinen et al. (2016) reported that percentages of Fe, Mn, Cr, Ni, and Mo of the total 
particle mass collected were 8.7, 2.7, 2.6, 1.4, and 0.3%, respectively, with multimodal 
particle size distribution in the range of 10–30 nm (Miettinen et al., 2016). Among the most 
common types of welding, only shielded metal arc welding generated the highest 
manganese release (up to 10% of PM2.5 mass concentration), although this was 4-fold less 
than iron concentrations (Oprya et al., 2012). Actually, many epidemiological studies of 
neurobehavioral impairments in welders have focused on manganese exposure. In 2013, 
Park performed a systematic review of 28 such studies (Park, 2013). He concluded that 
welders and other workers with known or likely sustained exposures to respirable Mn are at 
risk for developing neurological effects, such as performance decrements on standardized 
neuropsychological tests and adverse symptoms, and that these effects are consistent with 
signs of early manganism. Some data suggest that Mn exposures increase the risk of 
Parkinson’s disease and may disrupt dopamine metabolism (Park, 2013). However, the 
hypothesis of accelerated onset or early detection of Parkinson’s disease in these workers 
remains unconfirmed, even when considering more recent studies. Tescke et al. (Teschke et 
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al., 2014) found a three-fold increased risk of Parkinson’s disease in welders, but this finding 
was not statistically significant. In contrast, Van der Mark et al. observed reduced 
Parkinson’s disease risk associated with exposure to welding fumes (van der Mark et al., 
2015). The effects of other nanoparticulate components of welding fumes have attracted 
scientific interest only recently. Nevertheless, despite potential indirect neurotoxicity of 
nanoparticles, all identified studies were performed but regardless of their potential 
neurobehavioral consequences (Brand et al., 2014; Jarvela et al., 2013; Kauppi et al., 2015; 
Kim et al., 2005; Scharrer et al., 2007). These studies investigated the association between 
nanoparticle exposure and inflammation and oxidative stress at both, pulmonary and 
systemic levels in voluntary welders. 
Kauppi et al. (Kauppi et al., 2015) analyzed platelet counts, leucocytes and their differential 
counts, hemoglobin, sensitive C reactive protein (CRP), lipids, glucose and fibrinogen, 
interleukins IL-1β, IL-6, IL-8, TNF-α, endothelin-1, and E-selectin in plasma samples collected 
from 16 welders with suspected occupational asthma. Based on the observed increased level 
of blood leukocytes, neutrophils, and platelets, and the decreased level of hemoglobin and 
erythrocytes, they concluded that a mild systemic inflammatory response takes place during 
welding exposure, in line with the results of earlier studies (Jarvela et al., 2013; Kim et al., 
2005; Scharrer et al., 2007). However, they observed no statistical difference whether in CRP 
or in acute-phase mediators IL-6, IL-8, and TNF-α, while pro-inflammatory cytokine IL-1β and 
E-selectin levels decreased significantly. Although no study allows comparison with the latter 
finding, existing studies on CRP are still contradictory: Kim et al. (2005) (Kim et al., 2005) 
support significant CRP changes related to welding fume exposure, while Brand et al. (2014), 
Järvelä et al. (2013), and Scharrer et al. (2007), (Brand et al., 2014; Jarvela et al., 2013; 
Scharrer et al., 2007) do not. Very recently, Grazcyk et al. (Graczyk et al., 2016b) collected 
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exhaled breath condensate, blood and urine from 20 non-smoking male welding apprentices 
at different time points: 1)-before exposure, 2)-immediately after exposure, 3)-one hour 
after exposure, and 4)-three hours after exposure to assess oxidative stress biomarker 
concentrations (8-hydroxy-2'-deoxyguanosine, malondialdehyde, hydrogen peroxide, and 
total reducing capacity) at each time point. Significant increases in the measured biomarkers 
were observed at 3 h after exposure (a 24%-increase in concentrations of plasma hydrogen 
peroxide, a 91%-increase in urinary hydrogen peroxide, a 14%-increase in plasma 8-hydroxy-
2'-deoxyguanosine, and a 45%-increase in urinary 8-hydroxy-2'-deoxyguanosine). After 
doubling the particle number concentration, a significant 22%-increase in plasma 8-hydroxy-
2'-deoxyguanosine level was observed at 3 h post-exposure. The authors concluded that one 
hour exposure to Tungsten Inert Gas (TIG) welding fumes in an experimental, well-ventilated 
setting during one hour resulted in acute oxidative stress three hours after exposure in 
healthy, non-smoking apprentice welders with no previous chronic exposure to welding 
fumes. Since inflammation and oxidative stress (Song et al., 2016) are currently considered 
the two main mechanisms of nanoparticle-related neurotoxicity, these findings suggest that 
nanoparticulate components of welding fumes might be harmful for the human CNS. 
6.2. Studies of occupational combustion-resulting nanoparticles and their effects on 
human central nervous system 
Since manufactured nanoparticles may also induce direct and indirect genotoxicity on the 
basis of experimental studies, epidemiological case-control studies of CNS cancers were 
recently reanalyzed in order to assess the relationship with incidental occupational 
nanoparticle exposure. In 2016, Lacourt et al. (Lacourt et al., 2016) reanalyzed data from the 
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CERENAT study (Coureau et al., 2014) including 596 cases of CNS cancer diagnosed between 
2004 and 2006, and 1,192 controls. Exposure to nanoparticles was assessed via the job 
exposure matrix “MatPUF”, linked to the individual occupational histories of study 
participants. A significant association between occupational exposure to nanoparticles and 
CNS tumors was seen among men, who had a 50% increased risk of CNS tumors compared to 
controls (OR=1.5; 95% CI: 1.1, 2.2). The increased risk was particularly pronounced at high 
exposure levels and for exposure durations longer than 30 years (OR=1.9; 95% CI: 1.2, 2.8), 
as well as after exposure to carbonaceous nanoparticles (OR=1.5; 95% CI: 1.1, 2.3) and 
polycyclic aromatic hydrocarbons (OR =1.6; 95% CI:1.1, 2.4) (Lacourt et al., 2016). The results 
of analyses by histological subtype of CNS tumor (neuroepithelial tumor/meningioma) were 
not statistically significant, although the risk observed for meningioma was increased two-
fold in the nanoparticle-exposed subgroup (OR=2.0; 95% CI: 0.8, 5.3). In the INTEROCC case-
control study no association was found between occupational exposure to combustion 
resulting particulate material that could be emitted at nanoscale, namely benzo(a)pyrene, 
gasoline and diesel exhaust emissions and glioma tumors (Lacourt et al., 2013). These three 
combustion products presented a very similar pattern of results. There was neither an 
indication of increasing risk when comparing subgroups according to their exposure status 
(ever/never), nor clear dose–response relationship. Nevertheless, a borderline significant 
odds ratio of 1.3 (95% CI: 1.0, 1.8) was found in the highest category of diesel exhaust 
exposure duration (Lacourt et al., 2013). Although an increased brain cancer risk has been 
reported among motor vehicle operators (Carozza et al., 2000; Cocco et al., 1998; Krishnan 
et al., 2003), no other studies support the association between diesel or gasoline exhaust 
emissions and CNS cancer. 
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6.3. Studies of environmental air pollution nanoparticles and their effects on human 
central nervous system 
6.3.1. Studies in adult populations 
Given the similarity of air pollution components, namely fine (PM2.5) and especially ultrafine 
(PM0.1) particles, with carbonaceous and metal manufactured nanoparticles, studies of 
healthy or vulnerable adults and children heavily exposed to outdoor air pollution also shed 
interesting light on nanoparticle-related neurobehavioral effects. Tzivian et al. (2015) 
identified ten studies published up to November 2013 focused on the effects of 
environmental exposure on mental health in adult population, including mood disorders, 
neurocognitive function, and neurodegenerative diseases (Tzivian et al., 2015). This review 
was supplemented by adding four studies published post 2013 (Bakian et al., 2015a; Bakian 
et al., 2015b; Kioumourtzoglou et al., 2016; Schikowski et al., 2015; Wu et al., 2015) as 
summarized in Table 1. Although the results were presented in a heterogeneous way, 
hampering quantitative comparison between studies, this review supports, in overall, a 
possible role of airborne environmental particulate pollutants on neurocognitive function in 
the adults. No study analyzed the relationship between the PM0.1 fraction and 
neurocognitive outcomes. PM2.5 was significantly associated with global cognitive decline, 
assessed by the Mini-Mental State Examination (MMSE), in two Chinese (Sun et al., 2012; 
Zeng et al., 2010) and two American studies (Loop et al., 2013; Weuve et al., 2012), but not 
in a German study (Schikowski et al., 2015). The latter study was conducted in elderly 
women and used a cross-sectional design. The cognitive performance of 789 participants 
was assessed by the neuropsychological test battery of ‘The Consortium to Establish a 
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Registry for Alzheimer's Disease (CERAD)-Neuropsychological Assessment Battery and 
CERAD-Plus subtests for four specific cognitive domains: executive function, constructional 
praxis, semantic memory, and episodic memory. Figure copying, a subtest of constructional 
praxis, was negatively associated with all particulate components of air pollution. The 
strongest association was observed for NO2, NOx and PM10. For PM2.5, the association was 
of similar magnitude but not statistically significant (Schikowski et al., 2015). The association 
between PM2.5 and traffic load was evident only among carriers of the APOE ε4 risk allele. 
The APOE gene regulates cholesterol/lipid metabolism and the ε4 haplotype is a well-
described risk factor for impaired cognitive function and Alzheimer's disease (Corder et al., 
1993; Strittmatter et al., 1993). In contrast, Gatto et al. (Gatto et al., 2014) reported an 
association between PM2.5 and poorer verbal learning in a cross-sectional study of two 
distinct populations, while no association was found between PM10 and gaseous pollutants. 
Four studies where traffic-related air pollution effects were investigated using two exposure 
variables: black carbon concentrations and proximity to the road (Power et al., 2011; Power 
et al., 2013; Wellenius et al., 2012), and a study performed by Ranft et al. (Ranft et al., 2009), 
supports an association between the increase in black carbon levels and worse MMSE scores 
and poorer results on additional specific cognitive tests. The association between particulate 
air pollution and neurodegenerative diseases such as Parkinson's disease, Alzheimer's 
disease and dementia has been investigated in five studies. Two studies performed by 
Calderón-Garciduenas et al. (Calderon-Garciduenas et al., 2004; Calderon-Garciduenas et al., 
2010) pointed out more extensive changes related to Alzheimer’s disease in individuals 
exposed to higher air pollution. This changes included accumulation of Aβ42, increase in 
expression of COX2, and reduction in olfactory functions, respectively. Finkelstein and Jerrett 
(Finkelstein and Jerrett, 2007) reported that Parkinson's disease prevalence was associated 
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only with increasing ambient manganese concentration, but not with NO2 concentrations. 
Wu et al. (Wu et al., 2015) found that the highest tertile of PM10 (49.23 mg/m3) and ozone 
(21.56 ppb) exposure was associated with increased risk of vascular dementia and 
Alzheimer's disease. PM2.5 exposure data were unavailable, but given that PM10 and PM2.5 
had a high correlation (0.81) in this study, the authors considered that PM10 may serve as a 
surrogate of PM2.5 (Wu et al., 2015). 
Most recently, Kioumourtzoglou et al. (Kioumourtzoglou et al., 2016) studied the effects of 
PM2.5 on first hospital admission for dementia, Alzheimer's disease, and Parkinson's disease 
among around 9.8 million Medicare beneficiaries ≥ 65 years in 50 northeastern U.S. cities. 
The cohort was followed up from 1999 towards 2010 and allowed analyzing relationships 
between long-term city-wide exposure to PM2.5 and the three health outcomes. The hazard 
ratios (HR) were reported per 1μg/m3 increase in annual PM2.5 concentrations: 1.08 (95% 
CI: 1.05, 1.11) for dementia, 1.15 (95% CI: 1.11, 1.19) for Alzheimer's disease, and 1.08 (95% 
CI: 1.04, 1.12) for Parkinson's disease admissions. The authors interpreted these findings as 
an indication that PM2.5 environmental exposure might accelerate the progression of 
neurodegeneration, especially after the disease onset, and emphasized the role of 
inflammation as an intermediate outcome between PM2.5 exposure and the 
neurodegeneration (Block and Calderon-Garciduenas, 2009). Three studies assessed 
associations between air pollution index and anxiety, mood disorders, and activities of daily 
living, and reported that increase in air pollution was associated with poor self-reported 
health (Persson et al., 2007; Sun and Gu, 2008; Zeng et al., 2010). Lim et al. examined a 
relationship between air pollution and depression in a longitudinal study of 357 residents in 
Korea (Lim et al., 2012). Increased levels of PM10, O3 and NO2 were associated with increase 
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in the emotional symptoms of depression, while PM10 exposure additionally increased the 
frequency of somatic and affective symptoms (Lim et al., 2012). 
6.3.2. Studies in pediatric populations 
Calderón-Garcidueñas et al. (Calderon-Garciduenas et al., 2015) reviewed studies on the 
impact of air pollution on the CNS in pediatric populations, mostly considering studies in 
children from the highly polluted Mexico City Metropolitan Area. The authors concluded that 
the emerging picture for children in the Mexico City Metropolitan Area consists of systemic 
inflammation oxidative stress and immuno-dysregulation at both the systemic and brain 
levels, neuroinflammation, disorders in small blood vessel, intrathecal inflammatory process, 
as well as the early neuropathological hallmarks of Alzheimer’s and Parkinson's diseases. 
They considered that the developing brain in exposed children responds to the harmful 
environment by structural and volumetric changes, leading to cognitive, olfactory, auditory 
and vestibular deficits, and long-term neurodegenerative consequences (Calderon-
Garciduenas et al., 2015). When considering this alarming picture, it is important to keep in 
mind the high level of uncertainty and methodological limitations in most studies, which 
may undermine credibility. These limitations include small study samples, selection and 
exposure misclassification bias, and use of poor-quality aggregated exposure data, 
hampering control even for well-established confounders. For instance, Tzivian et al. (Tzivian 
et al., 2015) criticized the lack of joint consideration of noise exposure when studying the 
effects of traffic-related air pollution, due to possible synergistic relations or interactions 
between these two exposures. Kristiansson et al. (Kristiansson et al., 2015) emphasized the 
need for prospective longitudinal epidemiological investigations of associations between 
high concentrations of air pollutants, poverty, violence and health. To date, only one study 
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has met these requirements (Sunyer et al., 2015), confirming reduced cognitive 
development in children highly exposed to traffic-related air pollutants in Spanish schools. In 
this study, outdoor ultrafine particle (PM0.1) concentrations were associated with 
inattentiveness and reduction of superior working memory in the 12-months change model, 
after adjustment for sex, age, maternal education, air pollution exposure at home, and 
residential neighborhood socioeconomic status. In this model, the individual and school 
were treated as nested random effects and residual confounding by noise. Moreover, any 
residual confounding by noise was ruled out after checking the correlation between noise 
and different pollutants in the same classrooms, and the robustness of the coefficients for 
the pollutants by additional adjustment for noise and for the interaction between age and 
noise (Sunyer et al., 2015). 
Overall, the available evidence points to vulnerability of the developing brain to particulate 
components of air pollution. This is compatible with most currently considered neurotoxic 
mechanisms of ultrafine particles, such as inflammation, altered innate immune response, 
and chronic microglial stimulation. Given that microglial inflammation may result from both 
local deposition of ultrafine particle in the brain and systemic inflammation originating in 
more distant ultrafine particles-exposed organs (Block et al., 2012; Viana et al., 2014), the 
risk of neurobehavioral impairments in adults occupationally exposed to anthropic and 
manufactured nanoparticles cannot be excluded. 
7. Gaps in research and methodological challenges
Currently available studies are insufficient to elucidate the complex issue of how the brain 
manages  nanoparticles. Are they modified, removed or instead retained in the CNS? The 
fact that certain manufactured  nanoparticles, like TiO2, could be detected in the vesicles of 
33 
microglial cells suggests that the brain is able to activate classic elimination processes. 
However on a longer time scale in particular, there is no evidence on the actual ability of 
nerve cells to eliminate  nanoparticles. Instead, recent findings are in favor of nanoparticle 
accumulation in the brain over time. As an example of intracerebral persistence of 
manufactured  nanoparticles, multi-wall carbon nanotubes have been observed nearly one 
year after single aerosol exposure in mice (at 5 mg/m3 for 5 h) (Mercer et al., 2013). Another 
example from nanomedicine area could be found with biostability studies of gallium 
phosphide (GaP) nanowires (Gallentoft et al., 2016). Characterized with a diameter in the 
nanometer range and a length on the micrometer length scale, these nanowires have been 
shown to promote neurite outgrowth and reduce glial cell spreading (Piret et al., 2013; Piret 
et al., 2015), thus offering useful advantages in medical applications such as nanostructured 
electrode surfaces, by improving recording properties and reducing tissue responses (Piret 
and Prinz, 2016). The biostability in the brain of female rats was compared between 
degradable nanowires (coated with a 20nm layer of SiOx) and biostable nanowires (coated 
with a 20 nm layer of HfOx) known to persist in the brain for long periods of time (Gallentoft 
et al., 2015). In both cases, residues from nanowires remained detected in brain tissue 
1 year post injection, trapped in the microglia/macrophages, indicating a very slow clearance 
(dissolution and removal) of nanoparticles from the brain (Gallentoft et al., 2016). These rare 
long term studies stress the possible limits of degradation pathways in the brain and raises 
the question of the consequences that would have been observed on chronic exposure. 
Furthermore, it is highly likely that the nature of the  nanoparticles may also be a key 
element in the ability of the brain to eliminate or in contrast to accumulate  nanoparticles. 
Despite scant available evidence, based on often imperfect studies, it seems reasonable to 
point out that metallic nanoparticles are the most dangerous to the brain due to their 
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natural tendency to accumulate over time. Interestingly, metals such as iron, manganese, 
copper or zinc, are in fact retained in the brain during normal development with regional 
specificity (Tarohda et al., 2004), a phenomenon that worsens over time. This point is 
noteworthy when studying long-term impacts of  nanoparticles on the brain, since abnormal 
levels of metals are also associated with neurodegenerative diseases, and more specifically 
the neuronal populations affected by the disease (Davies et al., 2014). 
Given the limited literature available, an attempt to classify the deleterious effects induced 
by  nanoparticles is still impossible. However, based on in vitro studies dealing with the 
integrity of the BBB, it can be suggested that silver  nanoparticles may be more deleterious 
than copper  nanoparticles, themselves more harmful than aluminum  nanoparticles. While 
the combination of several metallic  nanoparticles is often more realistic in occupational and 
environmental settings, there is no study dealing with mixed nanoparticle exposure. A recent 
review article proposes an in-depth examination of the physicochemical properties of 
engineered nanomaterials that may impact their ability to interact with the nervous system, 
reporting how they contribute to nanoparticle distribution in the brain as well as how they 
may induce effects on it, bringing further evidence of possible nano-brain interactions 
(Yokel, 2016b). 
Given the specificities of brain composition and function, it is clear that very careful 
attention must be paid to the diverse experimental designs used when studying the effects 
of nanoparticle exposure on brain health. Nano-brain studies must indeed follow specific 
strategies and require a minimum of knowledge in neuropathology. Unfortunately, several 
published studies do not meet such requirements. Despite an attempt to alert the scientific 
community on the limitations of these studies (Bencsik and Lestaevel, 2015; Bencsik et al., 
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2013; Jonaitis et al., 2010), some of the results are still quoted as proven observations, 
needlessly fueling controversy that may lead to incorrect scientific conclusions and 
inappropriate regulatory responses. Any over-interpretation of data collected on one type of 
cell, on stressed or anesthetized animals, using unrealistic amounts of  nanoparticles, or 
unrealistic routes of exposure, should be carefully avoided. With respect to in vivo access of 
nanoparticle within nervous cells of the brain, attention must be paid on how the data were 
collected notably to differentiate between nanoparticles within the brain proper (brain cells 
and brain extracellular space) versus nanoparticles in brain that also contains the vascular 
compartment. This is important to avoid a false conclusion, often drawn, that a nanoparticle 
entered the brain, when it might be on the blood side of the BBB or within the BBB 
components, but not the brain. The in vivo studies are more illustrative of the situation in 
living beings. However, experiments in animals are challenging to control and could be 
affected by several random issues. Additionally, other parameters, such as the bio-
distribution of  nanoparticles, could possibly lead to inaccurate results. 
The in vitro models could help to assess the neurotoxicity of  nanoparticles. These models 
reflect our current mechanistic understanding of different cerebral effects. Protocols and 
methods are broadly well-known. In vitro models involve low costs, and provide high 
numbers of replicates. They raise few ethical difficulties, with the prominent exceptions of 
human tissue gift and embryonic stem cells. Cell models for practically all neuro-cellular 
types are available. For TiO2  nanoparticles for example, PC12, primary microglia, primary 
hippocampal neurons, human SH-SY5Y neuronal cells, human cerebral endothelial cells 
(HCECs), and human stem cell lines have previously been used (Coccini et al., 2015; Huerta-
Garcia et al., 2014; Rihane et al., 2016). Although the above-mentioned models were all 
dedicated on the harmful effects of TiO2  nanoparticles on the central nervous system, 
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different conclusions were found. Several factors, such as crystal type or size of 
nanoparticles, might influence the neurotoxicity of TiO2  nanoparticles examined in these in 
vitro models. Moreover, the wide relations among cells and/or tissues cannot be totally 
reproduced in these models. 
Current in vitro approaches for assessment of nano-neurotoxicity have important limits. In 
vitro tests are poorly interpretable in vivo, since the genotoxicity of  nanoparticles in cultures 
are not found in animal tests (Hartung, 2010). This divergence may be produced by limited 
nanoparticle bio-distribution within a cell compared with an entire organism, resulting in fast 
nanoparticle overload. A possible explanation of these limitations may result directly from 
the biological coating of the  nanoparticles. Although the phenomenon is far from being 
understood, it is recognized that the protein corona probably plays a crucial role in 
nanoparticle behavior in living beings once in contact with the complex biological milieu. The 
nature of the proteins that would bind to the surface of  nanoparticles will affect the 
properties of the  nanoparticles, guiding their interactions with cells (allowing endocytosis or 
not), and participating in the translocation process from one biological compartment to the 
other. Thus, protein coronas on  nanoparticles may act not only on bio-distribution, but may 
also play an important role for the functional properties of coated  nanoparticles, which can 
be beneficial as well as toxic for the body. As an example, the composition of the protein 
corona was studied for four different nanoparticles of SiO2 (combining 20 and 100 nm, with 
positive and negative charges), taking into account the composition in proteins specific to 
blood compared to brain homogenates. In plasma, the corona is mainly made of albumin, 
lipoprotein and proteins related to coagulation, while in the brain, it is mainly composed of 
tubulin, suggesting completely different interactions and functions of these  nanoparticles in 
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brain tissue (Shim et al., 2014). These major obstacles to assessing the neurotoxicity of 
nanoparticles are summarized in Figure 4. 
Besides, the knowledge in nanotoxicity and CNS in the biomedical field is deeply lacunar. 
Even if by definition brain nanomedicines will be optimized, today biocompatibility and 
biodegradability of nano-drugs are far to be understood. To our knowledge, there is no 
specific method to identify targeted drug release or the toxicity level in the brain. It appears 
that to improve safe nanotechnology–based drug for CNS disorders, specific guidelines 
should be also advanced and followed. 
8. Research avenues to gain insight in the raised questions
Over the past few years, there has been a continual debate on the most appropriate 
strategies to use for evaluating the human health risks of  nanoparticles on the brain. One of 
the utmost defies facing the neurotoxicology community is the prioritization of 
nanoparticles to estimate and the complexity of toxicological evaluation that should be 
directed. However, to date, the understanding of nanoparticle neurotoxicology has been 
particularly incomplete. The conclusions from classic in vitro and in vivo studies are not 
always comparable and are sometimes contradictory. Hence, it is crucial to normalize 
experiments that assess the neurotoxicity of  nanoparticles. This appears to be a key aspect 
in the biomedical context and probably some important advanced should come from 
nanomedicine studies. As an example, Kaushik et al. developed a promising biocompatible 
nanocarrier that could be helpful to follow brain delivery of nanoparticle and to evaluate 
their toxicity  (Kaushik et al., 2016). Relaying on the first step, in vitro cytotoxicity tests 
applied on primary human astrocytes and SKNMC neuroblastoma cell line, the authors 
completed their study by in vivo cytotoxicity tests in a mouse model (intra venous delivery at 
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a dose transposable to humans). Toxicity was assessed by histopathology, blood toxicity 
profile completed with neurobehavioral evaluation (grip test, horizontal bar test, rotarod 
test). The transmigration of the nanocarrier within the brain tissue, the particles size 
distribution as well as uptake in brains were analyzed using in situ transmission electron 
microscope (TEM) experiments. Brain tissues were also subjected to various analyses to 
evaluate elemental and structural analysis of the nanocarrier (scanning transmission 
electron microscopy (STEM), convergent beam electron diffraction (CBED), energy dispersive 
spectroscopy (EDS). A quantitative estimation of the nanocarrier concentration within the 
brain was performed using inductively coupled plasma mass spectroscopy (ICP-MS), 
validated by the previous establishment of calibration curves and appropriate control (of 
which control injected mice). Still this study does not evaluate the efficacy of the drug itself, 
neither the biodegradability of the nano-delivered medicine that would need long-term 
studies, in animal models but also in humans. For example, there is no long-term human 
safety information available for Nanotherm a magnetofluid consisting of superparamagnetic 
iron oxide nanoparticles (SPIONs), currently used for treating brain tumors (Gobbo et al., 
2015). The main hypothesis is based on the dissolution of the nanoparticle into ions that 
would be then recycled into the iron pool of the body in a homeostatic fashion. 
Moreover, because  nanoparticles could disturb brain homeostasis, the possible relationship 
between exposure to manufactured nanoparticle and neurodegenerative disorders needs 
further investigation. To do this, there are animal models for the common of nanoparticle-
induced neurodegenerative diseases, showing that the animal models have the same 
molecular targets or paths as humans. These animal models can be used for both sexes and 
at different life stages. Concerning animal studies, the importance of the life stage should be 
examined. First, fetal life and early childhood are critical stages and specific attention should 
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be focused on determining the effect of exposure to nanoparticle exposure at these 
developmental periods. Aging may also act as a significant feature in susceptibility to 
nanoparticle-induced neurotoxicity. The exposure scenarios should be realistic (exposure 
route, dose rate, exposure regimen, etc.), but conventional in vivo drug neurotoxicity testing 
methodologies are unfeasible, costly and time-consuming, even for  nanoparticles that have 
already been developed. 
Alternative neurotoxicity testing methods could help us to carefully study nanoparticle-brain 
interactions, such as innovative technologies that are rapidly developing and that contain 
imaging technologies as well as the different ‘‘omic’’ technologies. Because neurotoxicity 
investigations require extensive testing, the development of an intermediate in vivo 
screening platform would be most appropriate. Ideally this neuro-screening platform would 
rely on the mechanistic knowledge acquired in vitro and would provide relevant in vivo 
nano-neuro-interfaces, perfectly controlled in a spatiotemporal point of view. This platform 
must be in the same place and performs significant in vitro and in vivo studies on 
nanoparticles in the same time. It is also central to acquire information on how and where 
nanoparticles can accumulate in the brain, as well as nanoparticle elimination paths. It is 
possible that the cerebrospinal fluid could be an excretory path used by the central nervous 
system, and this subject should be studied as soon as possible. 
Most neurotoxic data on  nanoparticles gathered from experimental studies are based on 
rodents or their cells, and might be inappropriate to determine neurotoxicity in humans. 
Thus, studies on cells derived from humans would enhance our understanding of 
nanoparticle effects on the human nervous system, along with epidemiological and human 
controlled exposure studies. In conclusion, while the effect of  nanoparticles on the brain has 
recently received substantial attention, the data obtained from in vivo and in vitro studies 
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are nonetheless incomplete. In light of the most recent evidence of the presence of 
magnetite pollutant  nanoparticles detected in the brains of people living in contaminated 
cities, such as Mexico City or Manchester (Maher et al., 2016), better evaluation systems are 
urgently needed. 
9. Conclusion
Scientific articles dealing with neuro-nanotoxicology are received with particular interest, 
because in the field of nanotechnology, they will most likely have a significant impact not 
only on our perception of hazards potentially associated with nanomaterials, but also on 
regulatory decisions regarding their use in consumer products. Since the nervous system has 
many specificities in terms of vulnerability and protection systems, it needs particular 
attention and specific experimental and epidemiological studies relying on suitable 
approaches. Unfortunately, among the articles dealing with the specific question of brain–
nanoparticle interactions, only a few follow a suitable design and allow accurate conclusions 
that might be transposed to humans. In this context, particular attention must be paid to 
these studies. 
Thus, at a time when the use of the  nanoparticles is becoming increasingly widespread 
across different application areas, workers and consumers are exposed more and more, and 
by multiple pathways. This context of chronic exposure favors a potential impact on the 
vulnerable brain, in particular in susceptible periods of life (at the fetal age, and in young and 
elderly populations), as suggested by the most recent epidemiological studies. All the 
evidence already available fully justifies the need to evaluate the interactions between 
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nanoparticles and the nervous system specifically, and must lead to heightened awareness 
of the possible impact of nanoparticles on brain function. 
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Figure Legends 
Figure 1: In nanomedicine, nano-carriers help drug delivery to the brain by enabling passage 
across the BBB. Because nanoparticles (NPs) may induce neurotoxic effects, their use in the 
brain should be considered cautiously. Adapted from Nature Reviews, Drug discovery and 
from Khanna et al Nanomaterials 2015. 
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Figure 2: Schematic illustration of the nervous system’s main characteristics in terms of 
organization, composition, and protection. 
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Figure 3: Nanoparticle (NP) translocation to the nervous system: a summary of the main 
routes to the brain at the fetal, juvenile and adult stages of life, considering various routes of 
exposure, sites of uptake, and translocation pathways. 
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Figure 4: A schematic summary of the major obstacles to assessing the neurotoxicity of 
nanoparticles (NPs). 
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Tables 
Table 1: Results of studies on the effects of long-term air pollution on cognitive and psychological functions in adults. 
(Chen and Schwartz, 2009) 
Table 1. Results of studies on long-term air pollution effect on cognitive and psychological functions in adults. 
Authors, year of 
publication 
Study design Study 
population N 
(age) 
Exposure Covariates Outcome Obtained results 
Sun and Gu, 2008 Cross-sectional N = 7358 (83.6 
± 11.4) 
API P, L, E Cognitive 
functions 
1 unit air pollution index (API): For high gross domestic product (GDP): MMSE score 
β=−2.67, p < 0.001. For medium GDP: MMSE score  β=−1.84, p<0.001 
Chen and Schwartz, 
2009  
Cross-sectional N = 1764 (37.4 
± 10.9) 
PM, O3 P, L, H Cognitive 
functions 
Increased PM10: SDLT β =0.48, 95% CI=0.27–0.68; SDST β = 0.10, 95% CI=0.05–
0.15. After adjustment for race and SES—non-significant effect. Increased O3: SDST 
β=0.11, 95% CI=0.01–0.22; SDLT β=0.52, 95% CI 0.03–1.01 
Ranft et al., 2009 Cross-sectional N = 399 (74.1 ± 
2.6) 
PM10 P, L, H, E Cognitive 
functions 
Traffic exposure: CERAD-plus battery β=−3.8, p < 0.1; Stroop test β= −5.1, p < 0.01; 
Sniffing test β=−1.3, p < 0.05 (age ≤ 74). No independent effect of PM10 
Zeng et al., 2010 Cohort follow-
up 7 years 
N = 15,873 
(86.3) 
API P, L Cognitive 
functions 
1 unit API: cognitive impairment OR = 1.009, p < 0.05 
Power et al., 2011 Cross-sectional N = 680 (71.0 ± 
7.0) 
BC P, L, H Cognitive 
functions 
BC (doubling concentration, µg/m3): MMSE OR=1.3, 95% CI 1.1–1.6 Wellenius et al., 
2012 100 m from major road: MMSE < 26 for at least college education OR= .54, 95% 
CI 1.10–2.17; for ≤77 years OR=1.34, 95% CI 1.01–1.76. Not associated with HVLT-R 
recognition, TMT Part A ad CIB. Interquartile increase in BC (0.11 _g/m3): MMSE < 
26, OR=1.15, p = 0.06; worse performance of HVLT = R immediate recall, p=0.046 
Wellenius et al., 
2012 
Cohort follow-
up (median), 
16.8 years 
N = 765 (78.1 
± 5.4) 
Proximity to nearest 
road, BC 
P, L, H Cognitive 
functions 
BC (doubling concentration, µg/m3): MMSE OR=1.3, 95% CI=1.1–1.6; 100 m from 
major road: MMSE < 26 for at least college education OR=1.54, 95% CI=1.10–2.17; for 
≤77 years OR=1.34, 95% CI=1.01–1.76. Not associated with HVLT-R recognition, 
TMT Part A ad CIB. Interquartile increase in BC (0.11 µg/m3): MMSE < 26, OR=1.15, 
p=0.06; worse performance of HVLT= R immediate recall, p = 0.046 
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Weuve et al., 2012 Cohort follow-
up 4.3 years 
N = 10,409 
(74.0 ± 2.2) 
PM10; PM2.5, Coarse 
PM 
P, L  Cognitive 
functions 
PM2.5–10: worse global cognitive score (p for trend 0.01); worse for highest vs. lowest 
level (p = 0.003). Highest vs. lowest quintile of PM2.5: changes in global cognitive 
score for women (p = 0.03). Global cognitive score (SD/2 years) per 10 µg/m3 
increment: PM2.5–10 −0.020 (95% CI 0.32 to −0.008); PM2.5: −0.018 (95% CI −0.035 
to 0.002) 
Gatto et al., 2014 Cross-sectional N = 1496 (60.5 
± 8.1) 
O3, NO2, PM2.5 P, L  Cognitive 
functions 
None association with global cognition. Per 10 µg/m3 PM2.5: lower verbal learning (β= 
−0.32, p = 0.05). NO2 > 20 ppb: lower logical memory (β=−0.62, p = 0.095). O3 > 49 
ppb: lower executive function (β= −0.66, p = 0.059). O3 range 34–49 ppb: higher logical 
memory—women (β= 0.46, 95% CI 0.09–0.83), adults ≥ 60 y. o. (β= 0.51, 95% CI 
0.11–0.91) 
Loop et al., 2013 Cross-sectional N = 20,150 
(64.0 ± 9.2) 
PM2.5 P, L, H, E Cognitive 
functions 
Per 10 µg/m3 PM2.5: for urban area—incident cognitive impairment OR=1.40 (95% CI 
1.06–1.85); for mixed areas—incident cognitive impairment (OR = 0.32, 95% CI 0.11–
0.98). No associations for rural area and total population 
Power et al., 2013 Cross-sectional N = 629 (70.0 ± 
7.1) 
BC P, L, H Cognitive 
functions 
BC (doubling concentration,  µg/m3): for lacked an HFE C282Y low MMSE (OR=1.37, 
95% CI=1.08–1.73); for at least one HFE H63D variant (OR=1.74, 95% CI=1.06, 2.87). 
HFE C282 modifies the association between BC and global cognitive function 
Schikowski et al. 
2015 
Cross-sectional N=789 (73.4 ± 
3.05) 
NO2,  NOx, PM2.5, 
PM10 
P, L, H, 
APOE ε4 
allele 
Cognitive 
functions 
Negative association with cognitive function and cognitive performance in the subtests 
for semantic memory and visuo-construction. Significant associations could be observed 
for figure copying with an interquartile range increase of NO2 (β=–0.28 (95%CI:–0.44;–
0.12)), NOx (β=–0.25 (95%CI:–0.40;–0.09)), PM10 (β=–0.14 (95%CI:–0.26;–0.02)) and 
PM2.5 (β=–0.19 (95%CI:–0.36;–0.02)).The association with traffic load was significant 
in carriers of one or two ApoE ɛ4 risk alleles 
Calderón-
Garciduenas et al., 
2004  
Cross-sectional  N = 19 (51.2 ± 
4.9) 
PM, O3 none Alzheimer’s 
disease 
Frontal cortex tissue: Elevation of COX2 mRNA in high-exposure group (p=0.009); 
elevation of COX2 immunoreactivity (p=0.01). Hippocampus tissue: Elevation in COX2 
mRNA in high-exposure group (p=0.045); no differences in COX2 immunoreactivity 
between high and low-exposure groups (p=0.37) 
Calderón-
Garciduenas et al., 
2010  
Cross-sectional  N = 87 (21.0 ± 
2.6) 
PM2.5–10, PM2.5 none Alzheimer’s 
disease 
Mean UPSIT scores lower for high-exposure group (p=0.03). No differences in UPSIT 
scores in different APOE statuses (p=0.52) 
Wu et al., 2015 Case–control 249 AD 
patients, 125 
VaD cases, and 
497 
controls 
PM10, O3 P, L, H, 
APOE ε4 
allele 
Alzheimer’s 
disease (AD) & 
vascular dementia 
(VaD) 
The highest tertile of PM10 (49.23 mg/m3) or ozone (21.56 ppb) exposure was 
associated with increased AD risk (highest vs. lowest tertile of PM10: AOR 5 4.17; 
highest vs. lowest tertile of ozone: AOR 5 2.00). Similar finding was observed for VaD. 
The association with AD and VaD risk remained for the highest tertile PM10 exposure 
after stratification by APOE 34 status and gender. 
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Finkelstein and 
Jerrett, 2007 
Case–control N = 1764 (37.4 
± 10.9) 
PM10, O3 P Parkinson disease 
(PD) 
10 µg/m3 increases in Mn: PD or Dopa prescription for men OR=1.041, 95% CI 0.997–
1.09; for female: OR=1.035, 95% CI 0.97–1.10. With type of clinic as confounder 
OR=1.044 (95% CI=1.00–1.09) 
Kioumourtzoglou 
eta l., 2016 
Cohort, follow-
up 10 years 
N=9817806 
(75.6± 7.6) 
Annual 50 city-average 
PM2.5 mass 
concentrations for the 
period of 1999–2010 
P, L, H, Dementia, 
Alzheimer’s & 
Parkinson’s 
diseases 
Significant associations of long-term PM2.5 city-wide exposure with all three outcomes: 
HR=1.08 (95% CI: 1.05, 1.11) for dementia, an HR= 1.15 (95% CI: 1.11, 1.19) for AD, 
and HR=1.08 (95% CI: 1.04, 1.12) for PD admissions per 1μg/m3 increase in annual 
PM2.5 concentrations. 
Persson et al., 2007 Case–control N = 22,693 
(43.0 ± 13.0) 
NOx, Wood burning; 
industrial smells 
P, H Anxiety Exhaust form traffic: anxiety OR=1.66, p=0.001 
Sun and Gu, 2008  Cross-sectional N = 7358 (83.6 
± 11.4) 
API P, K, E Activity of daily 
living (ADL) 
1 unit API: For high GDP: difficulties in ADL (β=−1.41, p < 0.01); instrumental ADL 
(β=−0.98, p < 0.001), self-related health (OR = 2.20, p < 0.001). For medium GDP 
instrumental ADL β=−0.6, p < 0.001, self-related health, (OR = 1.87, p < 0.001), no 
associations with ADL 
Zeng et al., 2010 Cohort follow-
up 7 years 
N = 15,873 
(86.3) 
API P, L Activity of daily 
living (ADL) 
1 unit API: increased ADL disability (25%, p < 0.001); increased health deficits (8%, p 
< 0.05) 
Lim et al., 2012 Longitudinal 
follow-up 3 
years 
N = 357 (71.0 ± 
5.0) 
PM10, CO, SO2, NO2, 
O3 
P, L, H Depression Interquartile increase of PM10: Increase in composite score of emotional symptoms: 
38.2%, p < 0.01, NO2 118.2%, p < 0.05. Increase in somatic symptoms score 38.9%, p < 
0.05. Increase in affective symptoms score 11.5%, p < 0.01. O3: Increase in composite 
score of emotional symptoms 132.5%, p < 0.05 
API-Air pollution index that includes SO2, NO2, PM10, CO, O3; BC-Black carbon; P—personal factors, including age, sex, socio-economic status (SES), occupation, marital status, ethnicity, childhood SES, education 
level, marital status, number of surviving children, country of origin number of living children. L—lifestyle factors, including smoking, drinking, exercise, leisure activities, dark fish consumption, computer experience, 
BMI. H—health-related factors, including number of consultations with general physician, asthma, diabetes, incident stroke, presence of depressive symptoms, dyslipidemia, hypertension, blood pressure, triglycerides, 
HDL. E—environmental factors, including indoor air pollution, temperature, season. OR-odds ratio; 95% CI, 95% confidence interval; HR-Hazard ratio;* modal age class; the relationship with suicide risk was analyzed 
based on the air pollutant concentration on the day of the suicide (lag day 0) and on each of the 3 days preceding the suicide (lag day 1, lag day 2, and lag day 3) for single and cumulative air pollutants. 
